Nebulizer today fill in as a niche product in the Delivery of high doses of drug in the respiratory tract with major applications in the treatment of asthma, obstructive pulmonary disease, etc.
AMI has effectively utilized Nebulizer as it requires minimal coordination and effort in comparison with Pressurized metered dose (PMDI) or dry powder inhalers (DPI).
IMT is a wholly-owned subsidiary of AVMD
IMT has been granted an exclusive global right to sell, manufacture and distribute specific ultrasonic nebulizer Technology by Sheiman Ultrasonics Research Foundation (SURF) in the field of Sexual Dysfunction. This right is now on a royalty free basis.
The Nebulizer Technology supported by AMI’s innovative product research can bring amazing long sex life cycles in Australian Families. AMI has always banked on evolutionary innovations to provide niche products in order to strengthen their position in helping Mens & women’s Health issues.
Comparison to Omron Device
Nebulizer Treatment Technology